The gradual release of COVID-19 restrictions in the spring of 2021 in Finland22 resulted in the circulation of seasonal HCoVs followed by an increase in anti-HCoV S1 antibody levels in the autumn 2021. Here, PSMD1 is linked to COVID-19.